Cost-of-illness of cholera to households and health facilities in rural Malawi
Open Access
- 21 September 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (9) , e0185041
Abstract
Cholera remains an important public health problem in many low- and middle-income countries. Vaccination has been recommended as a possible intervention for the prevention and control of cholera. Evidence, especially data on disease burden, cost-of-illness, delivery costs and cost-effectiveness to support a wider use of vaccine is still weak. This study aims at estimating the cost-of-illness of cholera to households and health facilities in Machinga and Zomba Districts, Malawi. A cross-sectional study using retrospectively collected cost data was undertaken in this investigation. One hundred patients were purposefully selected for the assessment of the household cost-of-illness and four cholera treatment centres and one health facility were selected for the assessment conducted in health facilities. Data collected for the assessment in households included direct and indirect costs borne by cholera patients and their families while only direct costs were considered for the assessment conducted in health facilities. Whenever possible, descriptive and regression analysis were used to assess difference in mean costs between groups of patients. The average costs to patients’ households and health facilities for treating an episode of cholera amounted to US$65.6 and US$59.7 in 2016 for households and health facilities, respectively equivalent to international dollars (I$) 249.9 and 227.5 the same year. Costs incurred in treating a cholera episode were proportional to duration of hospital stay. Moreover, 52% of households used coping strategies to compensate for direct and indirect costs imposed by the disease. Both households and health facilities could avert significant treatment expenditures through a broader use of pre-emptive cholera vaccination. These findings have direct policy implications regarding priority investments for the prevention and control of cholera.Keywords
Funding Information
- Bill and Melinda Gates Foundation (1106078)
This publication has 26 references indexed in Scilit:
- Updated Global Burden of Cholera in Endemic CountriesPLOS Neglected Tropical Diseases, 2015
- An Optimal Cost Effectiveness Study on Zimbabwe Cholera Seasonal Data from 2008–2011PLOS ONE, 2013
- The Value of and Challenges for Cholera Vaccines in AfricaThe Journal of Infectious Diseases, 2013
- When, How, and Where can Oral Cholera Vaccines be Used to Interrupt Cholera Outbreaks?2013
- The global burden of choleraBulletin of the World Health Organization, 2012
- Economic burden of cholera in the WHO African regionBMC International Health and Human Rights, 2009
- The High Burden of Cholera in Children: Comparison of Incidence from Endemic Areas in Asia and AfricaPLOS Neglected Tropical Diseases, 2008
- Controlling Endemic Cholera with Oral VaccinesPLOS Medicine, 2007
- Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique☆Vaccine, 2006
- Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.2003